Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Narrative) (Details)

v3.22.4
Intangible Assets (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended
Feb. 14, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Aug. 23, 2021
Finite-Lived Intangible Assets [Line Items]            
Impairment of intangible assets   $ 565,000   $ 565,000 $ 0  
Impairment of intangible assets $ 25,000          
Amortization of Intangible Assets   $ 49,000 $ 123,000 116,000 $ 211,000  
Patents and Licenses [Member]            
Finite-Lived Intangible Assets [Line Items]            
Amortization of Intangible Assets       47,000    
Intellectual Property [Member]            
Finite-Lived Intangible Assets [Line Items]            
Amortization of Intangible Assets       $ 69,000    
RubrYc Therapeutics, Inc. [Member] | Immune-Oncology Antibodies (RTX-003) [Member]            
Finite-Lived Intangible Assets [Line Items]            
Investment           $ 7,500,000